Nurix Therapeutics, Inc.
NRIX · NASDAQ
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$86 | -$43 | -$56 | -$59 |
| Dep. & Amort. | $5 | $5 | $4 | $4 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $10 | $10 | $9 | $9 |
| Change in WC | $16 | -$32 | -$14 | $0 |
| Other Non-Cash | -$2 | -$3 | -$4 | -$3 |
| Operating Cash Flow | -$57 | -$63 | -$61 | -$49 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3 | -$3 | -$3 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$103 | -$68 | -$110 | -$298 |
| Inv. Sales/Matur. | $156 | $142 | $139 | $160 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $50 | $71 | $26 | -$141 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1 | $0 | $1 | $199 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $1 |
| Financing Cash Flow | $1 | $0 | $1 | $201 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$6 | $8 | -$34 | $11 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $85 | $77 | $111 | $100 |
| End Cash | $79 | $85 | $77 | $111 |
| Free Cash Flow | -$60 | -$66 | -$65 | -$51 |